Kevin R. Parker
Enable Biosciences (United States)(US)Stanford University(US)
Publications by Year
Research Areas
CAR-T cell therapy research, CRISPR and Genetic Engineering, Biosimilars and Bioanalytical Methods, Immune Cell Function and Interaction, Transgenic Plants and Applications
Most-Cited Works
- → CRISPR-engineered T cells in patients with refractory cancer(2020)1,396 cited
- → Atlas of Subcellular RNA Localization Revealed by APEX-Seq(2019)626 cited
- → Transient rest restores functionality in exhausted CAR-T cells through epigenetic remodeling(2021)568 cited
- → Single-Cell Analyses Identify Brain Mural Cells Expressing CD19 as Potential Off-Tumor Targets for CAR-T Immunotherapies(2020)446 cited
- → Coupled Single-Cell CRISPR Screening and Epigenomic Profiling Reveals Causal Gene Regulatory Networks(2018)318 cited
- → Discovery and functional interrogation of SARS-CoV-2 RNA-host protein interactions(2021)211 cited
- → Enhanced safety and efficacy of protease-regulated CAR-T cell receptors(2022)192 cited
- → Mitigation of chromosome loss in clinical CRISPR-Cas9-engineered T cells(2023)174 cited
- → Transcript-indexed ATAC-seq for precision immune profiling(2018)160 cited
- → RNA-GPS Predicts SARS-CoV-2 RNA Residency to Host Mitochondria and Nucleolus(2020)156 cited